Regulatory Alert | Re-Classification of FPI as FDI
https://luthra.com/wp-content/uploads/2024/11/Final-Regulatory-Alert_re-classification-of-FPI-as-FDI_November-2024.pdf
Regulatory Alert | Re-Classification of FPI as FDI Read More »
https://luthra.com/wp-content/uploads/2024/11/Final-Regulatory-Alert_re-classification-of-FPI-as-FDI_November-2024.pdf
Regulatory Alert | Re-Classification of FPI as FDI Read More »
https://luthra.com/wp-content/uploads/2024/11/Competition-Newsletter-November-24.pdf
Competition Law Newsletter Read More »
https://luthra.com/wp-content/uploads/2024/11/Pharmaceutical-Bulletin-October-2024.pdf
Pharmaceutical Bulletin Read More »
https://luthra.com/wp-content/uploads/2024/11/October-2024-Edition.pdf
Dispute Resolution Newsletter Read More »
https://luthra.com/wp-content/uploads/2024/11/Competition-Law-Newsletter-October-2024-Edition.pdf
Competition Law Newsletter Read More »
https://luthra.com/wp-content/uploads/2024/11/DT-Newsletter-Sep-2024-Formatted.pdf
Direct Tax Newsletter Read More »
https://luthra.com/wp-content/uploads/2024/10/DT-Update-Direct-Tax-Vivad-Se-Vishwas-Scheme-2024.pdf
Direct Tax Vivad se Vishwas Scheme, 2024 Read More »
https://luthra.com/wp-content/uploads/2024/10/Regulatory-Update-NDCT-Rules.pdf
The New Drugs and Clinical Trials (Amendment) Rules, 2024 Read More »
https://luthra.com/wp-content/uploads/2024/10/September-2024-Edition.pdf
Dispute Resolution Newsletter Read More »